Genetics has played only a modest role in drug discovery, but new tech
nologies will radically change this. Whole genome sequencing will iden
tify new drug discovery targets, and emerging methods for the determin
ation of gene function will increase the ability to select robust targ
ets. Detection of single nucleotide polymorphisms and common polymorph
isms will enhance the investigation of polygenic diseases and the use
of genetics in drug development. Oligonucleotide arraying technologies
will allow analysis of gene expression patterns in novel ways. (C) Cu
rrent Biology Ltd ISSN 0958-1669.